New combo strategy aims to catch and remove leftover cancer after radiation

NCT ID NCT07636499

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial studies whether a combination of regular check-ups, scans, blood tests, and ultrasound can safely find and guide removal of remaining cancer in neck lymph nodes after standard radiation for advanced nasopharyngeal cancer. About 50 adults aged 18-70 with N3 stage cancer will receive standard chemoradiation, then undergo close monitoring. If suspicious nodes are found, patients may have a minimally invasive surgery called endoscopic selective neck dissection. The main goal is to see if this approach is safe and feasible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for N3 NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • West China Hospital of Stomatology, Sichuan University

    Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.